Showing results (811-820 of 1,209) with videos related to
Sort By:
Pageof 121
AIDS (London, England)|May 6, 2016
Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapyClaudia Stuehler, Claudia Bernardini, Luigia Elzi, et al.Microbial Pathogenesis|August 16, 2005
Haemophilus influenzae luxS mutants form a biofilm and have increased virulenceDayle A Daines, Marcella Bothwell, Jason Furrer, et al.AIDS (London, England)|July 20, 2002
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /lMilos Opravil, Bruno Ledergerber, Hansjakob Furrer, et al.Antiviral Therapy|February 5, 2008
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modificationOlivia Keiser, Jacques Fellay, Milos Opravil, et al.Journal of Medicinal Chemistry|February 12, 2008
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparumWolfgang Friebolin, Beate Jannack, Nicole Wenzel, et al.AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.Antiviral Therapy|September 13, 2005
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort studyJim Young, Rainer Weber, Martin Rickenbach, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2007
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort StudyBruno Ledergerber, Hansjakob Furrer, Martin Rickenbach, et al.The Journal of Biological Chemistry|August 12, 2011
NrdH-redoxin protein mediates high enzyme activity in manganese-reconstituted ribonucleotide reductase from Bacillus anthracisMikael Crona, Eduard Torrents, Asmund K Røhr, et al.The Journal of Antimicrobial Chemotherapy|June 18, 2011
Ageing with HIV: medication use and risk for potential drug-drug interactionsCatia Marzolini, David Back, Rainer Weber, et al.Pageof 121